Waud Capital was a tremendous partner over four years. Their team understood the needs of the CVR organization; they shared my vision of building a first-class vein treatment business; and they allowed us to focus on the medicine while providing exceptional guidance to our efforts to scale the company. When Waud Capital exited the business in early 2016, we had grown from 11 centers predominantly in the Washington, D.C. area to 44 centers in eight states.